The growing class of drugs known as GLP-1 receptor agonists are impacting diabetes treatment, but the route of administration is shifting to a key decision. Previously, these effective medications were prescribed solely in pill form. However, innovative skin applications are now being introduced, leading to many people to ask which form is better .